Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

Share

Biopharma AS

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 2,387 Less Arrow 2,163 More Arrow 2,531
Financial expenses 2 Less Arrow 0 Equal arrow 0
Earnings before taxes 517 Less Arrow 334 Less Arrow 83
Total assets 1,521 Less Arrow 1,001 More Arrow 1,548
Current assets 1,521 Less Arrow 1,001 More Arrow 1,548
Current liabilities 953 Less Arrow 407 More Arrow 1,165
Equity capital 494 More Arrow 497 Less Arrow 253
- share capital 3 Equal arrow 3 Equal arrow 3

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 32.5% More Arrow 49.7% Less Arrow 16.3%
Turnover per employee
Profit as a percentage of turnover 21.7% Less Arrow 15.4% Less Arrow 3.3%
Return on assets (ROA) 34.1% Less Arrow 33.4% Less Arrow 5.4%
Current ratio 159.6% More Arrow 245.9% Less Arrow 132.9%
Return on equity (ROE) 104.7% Less Arrow 67.2% Less Arrow 32.8%
Change turnover 335 Less Arrow -208 More Arrow 49
Change turnover % 16% Less Arrow -9% More Arrow 2%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.